The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
about
Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms.Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureusReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsChip-NMR biosensor for detection and molecular analysis of cellsThe bacterial cytoskeletonStress Physiology of Lactic Acid BacteriaHuman gut microbiota: repertoire and variationsStructure of the complex between teicoplanin and a bacterial cell-wall peptide: use of a carrier-protein approachMore than just recruitment: the X-domain influences catalysis of the first phenolic coupling reaction in A47934 biosynthesis by Cytochrome P450 StaHAccumulation of phosphatidic acid increases vancomycin resistance in Escherichia coli.Exploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.Alanine scan of [L-Dap(2)]ramoplanin A2 aglycon: assessment of the importance of each residue.Synthesis and combinational antibacterial study of 5''-modified neomycin.Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptidesPhosphinate analogs of D-, D-dipeptides: slow-binding inhibition and proteolysis protection of VanX, a D-, D-dipeptidase required for vancomycin resistance in Enterococcus faecium.VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function?Structural and topological differences between a glycopeptide-intermediate clinical strain and glycopeptide-susceptible strains of Staphylococcus aureus revealed by atomic force microscopyA spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolatesAnalysis of peptidoglycan precursors in vancomycin-resistant Enterococcus gallinarum BM4174Assembling the glycopeptide antibiotic scaffold: The biosynthesis of A47934 from Streptomyces toyocaensis NRRL15009A novel membrane protein, VanJ, conferring resistance to teicoplanin.X-ray crystal structure of teicoplanin A₂-2 bound to a catalytic peptide sequence via the carrier protein strategy.Role of murF in cell wall biosynthesis: isolation and characterization of a murF conditional mutant of Staphylococcus aureusTargeting the microbiota to address diet-induced obesity: a time dependent challenge.Synergistic interactions of vancomycin with different antibiotics against Escherichia coli: trimethoprim and nitrofurantoin display strong synergies with vancomycin against wild-type E. coliVancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate.Mechanism of action of oritavancin and related glycopeptide antibiotics.Heterologous expression in Escherichia coli of the first module of the nonribosomal peptide synthetase for chloroeremomycin, a vancomycin-type glycopeptide antibiotic.Overproduction of a 37-kilodalton cytoplasmic protein homologous to NAD+-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus.Specificity of induction of glycopeptide resistance genes in Enterococcus faecalisBacillus subtilis as a platform for molecular characterisation of regulatory mechanisms of Enterococcus faecalis resistance against cell wall antibiotics.Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus.The bacterial actin MreB rotates, and rotation depends on cell-wall assembly.Methicillin-resistant staphylococci: detection methods and treatment of infections.Cloning of the Staphylococcus aureus ddh gene encoding NAD+-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolateTarget identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactionsMultidrug Intrinsic Resistance Factors in Staphylococcus aureus Identified by Profiling Fitness within High-Diversity Transposon Libraries.Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptidesGlobal Association between Thermophilicity and Vancomycin Susceptibility in Bacteria.Antimicrobial resistance of Staphylococcus aureus: genetic basis.
P2860
Q24519040-42FBB85E-3B1D-480E-A727-69E49BAAF3A6Q24556635-DE57284A-0E6C-4AAA-9870-82F4000398E2Q24646677-3412367E-6521-48CE-9F44-A318D6357EB3Q24649550-1AC69BF3-6A07-45B5-8E49-37A106CBE292Q24669907-460518C3-1728-4C1B-B708-6D45243179C9Q26741272-A9CAED2D-4717-4E94-AE87-6654312788DFQ27020975-B3E52249-8E08-4DA7-8BB1-E60A5A8F57EAQ27676948-D6D7763C-F227-41F5-B3AB-B4466AE7FDDBQ27723434-ABF4710F-FEBB-40FD-8B67-AC088A044F9AQ30153380-07678482-1978-4F80-BF46-122B7B84BEE5Q33264418-174F9BED-6962-4965-B7D2-AB79250B408CQ33288904-0E03A678-193F-417E-B299-F3528A9DDA37Q33486457-AA202121-0C35-45B6-BFFE-FB76C6A09088Q33661713-7C5EE097-C9D4-450E-8230-5501511B906AQ33709387-DA52D657-F075-4D06-985F-26BFBCD2D604Q33740144-50AC2819-4583-4F0A-A202-891DBB058001Q33981064-D0346746-00CB-4B71-9AC2-E68A0BD435C1Q33981239-84D5C405-FEC3-4ECE-AB6D-7BA5E68DDC9EQ34060112-E131A206-4612-49B6-9F3A-20318C6D7D2FQ34066411-80F17DF7-1457-422E-8CEE-C822C353D155Q34122537-5A0DE78E-DCE8-487C-8BA6-515DAAB02D1FQ34211592-369A509C-2FC5-48AD-BDF0-261A129D63FAQ34514390-7C83AC45-2768-484B-B25E-7031B55CFCE4Q34770232-AAC5F60F-EDEC-4C34-8DDA-F1B3EDB56E68Q34922407-C14973F8-9369-42BF-8401-642E63B53BA4Q35021822-02DEE05F-67A5-406C-86FF-ECE538F5EAEAQ35066202-0DD277BC-59EF-4DB2-BB1F-B2079E80B5EDQ35106259-4C808953-93DE-4DEF-96A5-A88F6AD3F4B3Q35121917-3F9CF650-B146-4A25-BD76-BAD53D15FFDEQ35127887-19DEE635-CF8A-48F1-BF86-A63B40CE8648Q35133913-75F79231-8570-4254-A5BB-75C4D19B425DQ35137758-32A5BA4C-435C-4E64-8EEC-F46A97279833Q35229232-CED138BC-DE98-44EB-82E5-9D0F07B22BEBQ35566190-47315C63-8FE1-466F-97A4-E4DDCBC7C40EQ35631929-2EE30D21-3079-43E9-9A81-5E2138413294Q36017100-A3792889-9BFC-4F5C-9935-B02B3B10AE27Q36105516-FA60EA19-2696-435D-A404-12AC6FE43FC2Q36416681-B74D134F-DDF5-4FA3-A232-2A74413EB639Q36747106-D3128BCB-1886-4E36-9754-98AA801696A4Q37063182-AA51ADF7-58A3-473A-84DC-43FCF694FC90
P2860
The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
@en
type
label
The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
@en
prefLabel
The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
@en
P1476
The structure and mode of action of glycopeptide antibiotics of the vancomycin group.
@en
P2093
P304
P356
10.1146/ANNUREV.MI.38.100184.002011
P577
1984-01-01T00:00:00Z